CYTOKINETICS INC (CYTK)

US23282W6057 - Common Stock

70.11  -1.3 (-1.82%)

After market: 71.75 +1.64 (+2.34%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to CYTK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 97.56. This target is 39.15% above the current price.
CYTK was analyzed by 25 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CYTK.
In the previous month the buy percentage consensus was at a similar level.
CYTK was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 70.1160.6095.8897.56128.10 - -13.56% 36.76% 39.15% 82.71%
Up and Down Grades
Date Firm Action Rating
2024-03-07 JP Morgan Maintains Overweight -> Overweight
2024-03-06 Mizuho Maintains Buy -> Buy
2024-03-04 Oppenheimer Reiterate Outperform -> Outperform
2024-02-28 Needham Reiterate Buy -> Buy
2024-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-01-24 UBS Downgrade Buy -> Neutral
2024-01-22 Mizuho Maintains Buy -> Buy
2024-01-05 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-12-28 Raymond James Maintains Outperform -> Outperform
2023-12-28 Truist Securities Maintains Buy -> Buy
2023-12-27 Needham Maintains Buy -> Buy
2023-12-27 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-09 Goldman Sachs Initiate Buy
2023-11-07 B. Riley Securities Initiate Buy
2023-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-20 Needham Reiterate Buy -> Buy
2023-10-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-09 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-10-09 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-15 SVB Leerink Initiate Outperform
2023-08-04 Needham Reiterate Buy
2023-08-04 Morgan Stanley Reiterate Overweight -> Overweight
2023-08-04 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-22 Morgan Stanley Reiterate Overweight
2023-06-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-22 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-05-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-16 Oppenheimer Reiterate Outperform -> Outperform
2023-05-05 JMP Securities Reiterate Market Outperform